AI & Deep Tech VC Funds

OpenOcean is a leading pan-European venture capital firm focusing on early-stage investments, particularly in Series A rounds, with an emphasis on data economy, B2B platforms, and enterprise software technology. Founded by the team behind MySQL and MariaDB, OpenOcean leverages its deep technical expertise to identify and support innovative startups that can rapidly scale and achieve global adoption. Notable investments include Truecaller, which has grown into a prominent global communications platform with over 200 million daily active users, and MariaDB, a leading open-source database company that recently went public on the New York Stock Exchange. Other significant portfolio companies include Nosto, a marketing automation tool, and Supermetrics, a global leader in marketing data integration tools. OpenOcean’s investment strategy is data-driven and focuses on sectors such as AI, data infrastructure, DevOps, and automation. They typically invest up to €6 million per company, leading or co-leading the investment rounds. The firm has a strong commitment to fostering diversity and transparency within its portfolio companies, ensuring a supportive environment for founders. The team at OpenOcean, with offices in Helsinki and London, is known for its hands-on approach, helping startups navigate the complexities of scaling their businesses and achieving sustainable growth. This approach has led to the creation of several unicorns and high-growth companies that are transforming their respective industries.

Open Opportunity Fund is a venture and growth investment firm backing B2B software companies across Enterprise IT, Fintech, and People Ops. We focus on business-critical software fueled by cloud, AI, and agentic systems, with 70% of our portfolio companies based in emerging tech hubs across the U.S. in regions often overlooked by traditional VC. Fund I was a $100M vehicle and on the strength of that success, we are now raising Fund II. Our strategy combines early and growth-stage investing to back category-defining companies that transform how organizations manage infrastructure, streamline financial operations, and empower their workforces. The firm was founded by Paul Judge and Marcelo Claure, successful entrepreneurs who have each built and scaled companies to successful exits.

The OpenAI Startup Fund is a $175 million venture capital fund focused on investing in early-stage startups that are using artificial intelligence to create transformative change across a range of industries. These industries include healthcare, law, education, energy, and infrastructure. The fund seeks to partner with companies that are pushing the boundaries of AI technology, aiming to have a profound and positive impact on the world. Managed by a team with deep expertise in machine learning, engineering, talent acquisition, and operations, the fund leverages its connections with major investors like Microsoft. Although OpenAI itself is not an investor in the fund, the initiative is deeply tied to OpenAI’s mission of ensuring that artificial intelligence benefits all of humanity. The fund is particularly focused on empowering founders from underrepresented groups, emphasizing the importance of diversity in the tech industry. The OpenAI Startup Fund is not just a source of capital but also provides strategic support to its portfolio companies, helping them navigate the challenges of scaling AI-driven solutions. Startups that align with the fund’s mission of using AI to increase human productivity and address significant global challenges are encouraged to reach out. The fund represents a strategic effort to accelerate the deployment of ethical, impactful AI technologies that can reshape industries and improve lives.

OpenSpace Ventures is a prominent venture capital firm based in Southeast Asia, known for its strategic investments in transformative tech companies across the region. Established in 2014, OpenSpace Ventures has backed notable companies like Gojek, Halodoc, and Love, Bonito, which have made significant impacts in their respective industries. The firm focuses on sectors such as fintech, healthcare, e-commerce, and digital media. Their portfolio includes companies like Lista, a financial management platform for individuals and small business owners in the Philippines; Lucence, a precision oncology company; and Nutrition Technologies, which produces sustainable insect-based proteins for agriculture. OpenSpace Ventures employs a hands-on approach, providing not only capital but also strategic guidance and operational support to help their portfolio companies scale and succeed. They manage several funds, including those focused on Series A/B and mid-stage growth investments, and are recognized for their deep expertise and active involvement in the Southeast Asian startup ecosystem​.

OpenView Venture Partners, based in Boston, is a leading venture capital firm focused on expansion-stage B2B software companies. Founded in 2006 by Scott Maxwell, OpenView specializes in product-led growth (PLG), backing high-potential startups in sectors like SaaS, cloud computing, and productivity software. Notable investments include companies like Calendly, Expensify, and UserTesting, which have scaled into industry leaders with the firm’s support. OpenView typically invests between $5 million and $15 million, focusing on companies with $2 million to $20 million in revenue. Their strategy revolves around more than just capital; they provide operational expertise, assisting with areas like pricing, go-to-market strategy, and talent acquisition. Their value-add model means they work closely with portfolio companies to optimize growth and operational efficiency, helping founders build sustainable and scalable businesses. Geographically, OpenView invests primarily in North America, with a keen eye for businesses that are ready to transition from early traction to full-scale market dominance. The firm is known for its deep expertise in the enterprise software space and is selective about partnering with companies that align with its product-led growth thesis. The leadership team, including key partners like Blake Bartlett and John McCullough, are hands-on with portfolio companies, often playing a pivotal role in key hires and strategic decisions. OpenView is particularly known for its content and community efforts, offering valuable industry insights and resources to help software leaders grow faster.

Opera Tech Ventures is a Paris-based venture capital firm launched in 2018 as the investment arm of BNP Paribas. Specializing in fintech, insurtech, AI, sustainability tech, and enterprise software, Opera Tech Ventures targets startups with cutting-edge solutions in these sectors. They predominantly invest in Series A to D rounds, with a focus on scalable technologies that address critical market needs. The firm typically invests between $3 million and $15 million per deal, often taking a leadership role in the funding process. Their portfolio includes companies like SESAMm, an AI-driven analytics firm, Stoik in cloud security, and Arbol in commercial insurance. With a global scope, Opera Tech Ventures invests across Europe and North America, particularly favoring markets in France, the UK, the US, and the Netherlands. Their investment strategy is driven by a deep understanding of fintech and enterprise solutions, looking for startups that can revolutionize industries and show strong growth potential. Co-investing with well-known partners like Andreessen Horowitz and Munich Re Ventures, Opera Tech Ventures ensures their portfolio companies receive both capital and strategic guidance​. Under the leadership of Thibaut Schlaeppi, the firm is highly engaged in supporting portfolio companies beyond just financial backing. They offer insights, mentorship, and extensive connections across industries. Their diverse team brings expertise from multiple sectors, allowing them to help companies scale effectively in highly competitive markets. By focusing on innovation, Opera Tech Ventures continues to build a robust portfolio of future-leading companies.

Operator Collective, founded in 2019 and based in Palo Alto, California, is a venture capital firm that leverages a unique model combining capital with a community of experienced operators. The firm focuses on investing in early-stage B2B companies, primarily in enterprise tech sectors such as SaaS, AI, and data analytics. Notable portfolio companies include Ironclad, Guild Education, Faros AI, and Hex Technologies. Operator Collective typically invests in seed and Series A rounds, with an average investment size of $3M to $20M. The firm has built a reputation for its diverse and inclusive approach, drawing on the expertise of over 200 operator LPs who have scaled successful tech companies like Atlassian, Guild Education, and Toast. The team, led by founder Mallun Yen, brings extensive experience from the tech industry, providing hands-on support to portfolio companies. This support includes leveraging their substantial networks for strategic introductions and advice on scaling operations​. Operator Collective's investment strategy emphasizes not only financial backing but also operational expertise, aiming to drive growth and innovation in its portfolio companies​.

Operator Partners is a venture capital firm that uniquely operates with its own capital, investing in technology companies from the pre-seed to Series B stages. Founded and led by experienced entrepreneurs, the firm provides support beyond financial investment, focusing on helping companies with business building and scaling challenges that arise between board meetings. Operator Partners has a hands-on approach, offering guidance based on their own entrepreneurial experiences. They engage with founders on various aspects such as product development, customer acquisition, fundraising, recruiting, and establishing organizational culture. The firm does not lead funding rounds or take board seats but assists in finding lead investors if needed. The team includes General Partners Amit Avner, Gil Shklarski, Nat Turner, and Zach Weinberg, along with Partner Olivia Benjamin. This team brings extensive expertise from founding and scaling successful companies themselves, making them well-equipped to support their portfolio companies effectively.

Option3 Ventures (O3V) is a New York-based strategic cybersecurity-specialist private-equity and venture-capital firm founded in 2014 by Managing Partner Manish Thakur. The firm is singularly focused on cybersecurity, with an emphasis on Zero Trust architectures, Operational Technology and Industrial Internet of Things security, and network and firmware security. Rick Andlinger joined as Partner and Chief Investment Officer in March 2020, bringing more than 20 years of family-office private equity and VC leadership from Andlinger and Company. The firm's Technology Board includes former CIOs and board members of the US Department of Defense, CIA, and NSA. Option3 leads rounds and has historically operated three vehicles: C1 (2016), a portfolio of three minority investments; CS (2020), a Special Situations vehicle holding four minority stakes with selective board control; and CE (launched late 2023 through 2025), a single roll-up platform that acquires the CS portfolio companies and adds earlier-stage and mid-market Zero Trust businesses. Total current investments and deals exceed $100 million in AUM. Portfolio investments include Onclave Networks, a Zero Trust solution for industrial IoT that was acquired into the ENIGMA platform in August 2024; Veracity Industrial Networks, an SDN-based industrial security company; Dark Cubed, enterprise-grade cyber for SMBs; and Dellfer, an automotive and IoT firmware security company acquired in January 2025 with an additional investment in March 2025. The ENIGMA roll-up platform now fuses Onclave, Veracity, and Dellfer. Option3's sector specialization is its defining characteristic: by focusing entirely on cybersecurity and building a platform that consolidates complementary technologies, the firm acts as more than a financial investor — it functions as an architect of integrated security infrastructure.

Optum Ventures is an independent venture capital firm founded in November 2017 as a strategic partnership between UnitedHealth Group and its Optum subsidiary. Headquartered in Boston, Massachusetts with a second office in Menlo Park and London presence, the firm launched with an initial $250 million commitment and has since scaled to over $2 billion in assets under management across six successive funds. Its mission is to back the next generation of healthcare innovation, investing stage-agnostically from seed through growth equity in companies at the intersection of technology and healthcare. Partners include A.G. Breitenstein, Virginia McFerran, and Heather Roxborough. Optum Ventures leads rounds and its thematic priorities include digital health, data analytics, value-based care delivery, healthcare enterprise software, clinical AI, fintech and insurtech applied to healthcare, and enabling health-system infrastructure. The firm has deployed capital into more than 120 companies and holds five unicorns: Ambience, an AI ambient scribe company; DispatchHealth; and LetsGetChecked, among others. Recent activity includes Risa Labs in January 2026 as the most recent disclosed investment; Reema Health at Series B in December 2025; Headstart, an ABA autism-care platform backed in 2025; and CoPlane, which raised a $14 million seed round in 2025 for AI-native ERP workflow automation. Optum Ventures' differentiation lies in its deep commercial connectivity to UnitedHealth Group — the largest US health insurer and services company. Portfolio companies gain access to health plans, providers, employers, and patients through the UHG network, as well as Optum's health-services commercialization expertise. This combination of financial capital and strategic distribution makes Optum Ventures one of the most consequential healthcare-focused CVCs in the market.

Oraseya Capital is a Dubai-based VC fund launched in 2023 by the Dubai Integrated Economic Zones Authority. Backed by $136 million, it invests in UAE startups from pre-seed to Series B. The focus is on high-growth areas like fintech, edtech, digital health, AI, logistics, and the future of work. As a government-linked fund, it’s part of Dubai’s push to back local founders and build a strong tech ecosystem.

Orbia Ventures is the corporate venture capital arm of Orbia, a multinational company focused on advancing life globally. Orbia Ventures supports startups developing groundbreaking solutions in areas like climate tech, decarbonization, sustainability, circular economy, food security, water infrastructure, data access, and energy storage. With a strong commitment to addressing the world's biggest challenges, Orbia Ventures invests in early- and growth-stage companies that align with its mission to create resilient and future-fit communities. The firm provides more than just capital; it offers extensive business development support, operational expertise, and opportunities for commercial collaborations within Orbia’s broader network. Orbia Ventures helps build strong management teams and leverages its relationships to open new business opportunities for portfolio companies. Notable investments include Tortuga AgTech, which uses advanced robotics to enhance agricultural productivity, Verdagy, a leader in green hydrogen production, and Ascend Elements, which focuses on recycling lithium-ion batteries to create advanced battery materials. Other standout portfolio companies include Type One Energy (fusion energy), Deepomatic (AI-powered visual automation), and Greeneye Technology (precision agriculture). These companies reflect Orbia Ventures' commitment to driving impactful innovation across critical sectors.

OrbiMed is a leading healthcare-focused investment firm based in New York City, established in 1989. It manages over $18 billion in assets across various investment strategies, including public equity, private equity, and private credit/royalty investments. OrbiMed invests globally in companies spanning the healthcare sector, from biopharmaceuticals to medical devices and healthcare services. OrbiMed’s portfolio includes notable companies like Guardant Health, Adaptive Biotechnologies, and Apollomics, showcasing its strong presence in the biotech and medical device sectors. The firm is known for its ability to back innovative startups and has been instrumental in bringing over 60 new healthcare therapies to market​ ​. For startups and established companies looking to connect with OrbiMed, it is beneficial to demonstrate innovative healthcare solutions with strong potential for market impact. The firm typically leads investment rounds and provides significant strategic support to help companies grow into market leaders.

Oregon Venture Fund (OVF) is Portland's largest and most active early-stage technology investor, founded in 2007 as the Oregon Angel Fund and rebranded in 2018 to reflect its evolution into a fully institutional venture vehicle. Managing Partner Eric Rosenfeld co-founded the firm and leads a platform that has grown to approximately $250 million in cumulative AUM, deploying $15 to $20 million annually through an annual-vintage model. Each year OVF forms a new limited partnership drawing from a community of 180-plus accredited venture partners who serve as both LPs and as active advisors, operators, and deal introducers for portfolio companies. The fund focuses exclusively on Oregon and Southwest Washington companies across stages from seed through Series B, with initial checks of $500,000 to $4 million and total reserves of up to $10 million per company. OVF leads rounds and has backed over 70 portfolio companies, including Absci (NASDAQ: ABSI, the largest biotech IPO in Greater Oregon history at $230 million), Jama Software, Elemental Technologies, Brandlive, Salt and Straw, Wildfang, Conveyor, Hydrolix, and Lumen Learning. Through 2021 the firm reported a 34 percent average annual rate of return and a 3.5x gross multiple. OVF invests across software, biotech, health technology, food and beverage, and AI, reflecting the diverse character of the Pacific Northwest technology ecosystem it helped build. The firm's community-LP model means that portfolio founders gain not just capital but introductions to operators and executives with deep Pacific Northwest networks, giving OVF a differentiated value proposition relative to coastal generalist funds.

Origin Ventures is an early-stage venture capital firm based in Chicago, Illinois, founded in 1999 by Steve Miller and Bruce Barron. The firm focuses on investing in high-growth software, marketplace, and consumer businesses that are shaping the Digital Native Economy. Origin Ventures has a strong track record, having raised over $300 million across multiple funds and achieving notable exits with companies like Grubhub, Cameo, Fountain, and Tock​. The firm recently closed its fifth fund at $130 million, exceeding their initial target despite the challenges posed by the COVID-19 pandemic. This new fund continues to emphasize investments in the Digital Native Economy, targeting themes such as the workplace of the future, the creator economy, and the circular economy. Recent investments from this fund include companies like Blueboard, Vivrelle, Veho, Lumanu, and Everee. Origin Ventures operates with a thesis-driven approach and maintains a presence in all four continental U.S. time zones, with offices in Chicago, Salt Lake City, San Francisco, and Washington, D.C. This geographic diversity allows them to be close to elite teams and investment opportunities across North America​. The firm prides itself on its hands-on partnership with founders, offering extensive support from their experienced team of former entrepreneurs, operators, and engineers. This commitment has helped them build a portfolio of companies that have consistently delivered strong returns and defined new market categories.

Orion Venture Partners is an early-stage venture capital firm headquartered in Palo Alto, California, operating the Orion Opportunity Fund I, established in 2019. Though the current fund vehicle was formed that year, the underlying investment team has been active since 2001, having invested in 43 companies with approximately $889 million of cumulative capital deployed and an 87 percent average IRR across trade-sale and IPO exits. The firm positions itself as a differentiated, hands-on investor working alongside founders to scale into category-defining platforms, describing its partners as 'early investors, long-term partners.' The fund's investment parameters include a five-year investment period, early-stage checks of $100,000 to $500,000, and growth-stage checks of $1 million to $5 million, with a target ownership of 7 percent or more per position. Geographic focus spans Greater China and the United States, with a particular emphasis on cross-border technology plays. Thematic priorities include artificial intelligence, medical technology, media and content, retail services, mobile content, wireless and telecom infrastructure, and sports technology. From the 2019 vintage, Orion has made 10 disclosed investments, with notable portfolio companies including Avesha (Kubernetes application services), Verana Networks (5G radio access network equipment), and Paw Paw (consumer food products). Orion Venture Partners takes a long-duration approach to company building, leveraging its partners' two-decade track record of cross-border investing to provide founders with both capital and strategic access across the US and Asia-Pacific markets.

ORIX Growth Capital (formerly ORIX Venture Finance and ORIX Ventures) is the growth-finance and venture-debt business of ORIX Corporation USA, the US hub of Tokyo-listed international financial services group ORIX Corporation, which operates across 30 countries. Founded in 2001 and headquartered in New York with additional presence in Dallas, the group rebranded to ORIX Growth Capital to better reflect its positioning as a specialist provider of debt and equity capital to venture-backed, high-growth companies rather than a traditional equity VC. The platform is led by Jeff Bede as Head of Growth Capital, alongside Managing Directors David Orlandella and Benjamin Wu, who heads the East Coast practice. Orix Growth Capital is an enterprise-value lender that scales individual facilities from $5 million to $100 million and deploys across the full capital stack, including senior secured unitranche, second-lien facilities, subordinated venture debt, and equity co-investments. Typical terms include five-year maturities, extended interest-only periods, and delayed-draw capability. Sector focus centers on technology and healthcare, spanning SaaS, software, biotech, fintech, and data analytics. Since 2001 the group has provided approximately $2.5 billion in financing to more than 200 companies and has recorded 45 portfolio exits. Recent activity includes a debt facility for Piano Software alongside Updata Partners' Series D equity round in February 2025. The firm leads transactions and provides capital-structure solutions that complement rather than compete with equity investors, giving founders growth runway with flexible repayment structures designed for SaaS and healthcare business models.

Oriza Ventures is a venture capital fund that focuses on early-stage technology investments, primarily in North America. Founded by seasoned entrepreneurs and investors, Oriza Ventures supports startups with disruptive technological pursuits and innovative business ideas. The firm's portfolio spans various industries, including artificial intelligence, big data, Internet of Things, consumer internet, and medical and health products. The team at Oriza Ventures includes founding partners John Yu, Alex Liang, and Yao Xiao, who bring extensive experience in venture capital and entrepreneurship. They leverage their backgrounds to provide strategic guidance and resources to their portfolio companies. Oriza Ventures' portfolio features a diverse range of companies such as Ayla Networks, an IoT platform for smart home appliances; Bolt, an online checkout platform; and InterVenn Biosciences, which uses AI-driven mass spectrometry for medical applications.

Orlando Health Ventures is the corporate venture capital arm of Orlando Health, one of Central Florida's largest nonprofit integrated healthcare systems, established in 2018 and based in Orlando, Florida. The unit sits inside the Orlando Health Strategic Innovations group alongside The Foundry, Orlando Health's internal innovation and rapid-prototyping engine, giving portfolio companies direct access to clinicians, operating executives, and service-line leaders for evaluation, piloting, and commercial validation. The fund targets early-stage companies whose technologies have the potential to transform care delivery, clinical workflows, and patient outcomes. Orlando Health Ventures has made approximately nine disclosed investments concentrated in medical devices and digital health. Portfolio companies include 410 Medical (rapid IV medication delivery, with a Series B-II round in March 2025 as the firm's most recent disclosed investment), Biostable Science and Engineering (Austin-based heart-valve repair device as an alternative to replacement, with roughly $1.25 million deployed), and Vesalio (neurovascular thrombectomy devices whose NeVa VS system launched at Wellstar Health System in Atlanta). The fund participates in seed through Series B rounds alongside peer health-system corporate venture arms such as UPMC Enterprises. What distinguishes Orlando Health Ventures is its combination of clinician-led diligence and operational pilot capability. Portfolio companies can run structured pilots within the Orlando Health system, gaining real-world evidence and commercial traction while the fund's investment committee evaluates growth trajectory and return potential. The result is a capital partner that brings both funding and a credible path to enterprise healthcare customers.

OS Fund, established in 2014 by Bryan Johnson, is a venture capital firm that invests in early-stage science and technology companies. The firm focuses on sectors such as genomics, synthetic biology, computationally derived therapeutics, advanced materials, and diagnostics. The goal is to support companies that are developing groundbreaking technologies and solutions to solve significant real-world challenges​. Bryan Johnson, who co-founded the fund, initially invested $100 million of his own money after selling his previous company, Braintree, to PayPal for $800 million. The fund seeks out entrepreneurs who are future-oriented and possess the ambition to create a better future for humanity​. OS Fund has a strong portfolio, including companies like Ginkgo Bioworks, Atomwise, and Verge Genomics. These companies are at the forefront of innovation, working on projects such as self-fertilizing crops, storing data in DNA, and designing new proteins.

Osage Venture Partners (OVP) is a Philadelphia-based venture capital firm that specializes in early-stage investments in B2B software companies. The firm primarily focuses on companies driving innovation in the future of work and education sectors. Since its inception, OVP has invested in over 30 companies, with a strong preference for those with recurring revenue models and deep domain expertise. Notable investments in their portfolio include companies like Sidecar, RiskLens, and ExecOnline. OVP typically invests in post-revenue companies with a revenue run rate between $500,000 and $3 million, focusing mainly on Seed and Series A rounds. They have a hands-on approach, often leading or co-leading investments and joining the boards of their portfolio companies. OVP emphasizes the importance of partnerships, leveraging their extensive network of technology executives and industry experts to support the growth and success of the companies they invest in. Their team is comprised of seasoned investors and former operators who provide strategic guidance and operational support to entrepreneurs.

OSF Ventures is the corporate venture capital arm of OSF HealthCare, a 15-hospital nonprofit integrated health system operating across Illinois and Michigan. Founded in 2015 and headquartered in Peoria, Illinois, OSF Ventures sits within OSF Innovation and invests financially, operationally, and strategically in healthcare companies whose technologies can improve patient outcomes, enhance patient experience, and reduce the cost of care. Mayank Taneja, Vice President of Venture Investments, leads a seven-person team across three successive fund vintages that have grown cumulative AUM to $250 million, anchored by Fund III, a $100 million vehicle launched in January 2022 with a thesis tilt toward alternative care modalities and healthcare workforce retention. The firm participates as a syndicate member at Series A through growth stages and has made approximately 37 investments spanning health information technology, medical devices, therapeutics, diagnostics, and technology-enabled care delivery. The portfolio has produced notable exits including Current Health (acquired by Best Buy in 2021), Health Catalyst (NASDAQ IPO in 2019), and SilverCloud Health (acquired by Amwell in 2021). Recent deployments include Hellocare.ai, Cala, ShiraTronics, Cardiosense ($15.1 million Series A for an AI heart disease biomarker platform), 410 Medical ($6.3 million Series B for pediatric sepsis), and Digital Diagnostics ($75 million Series B, autonomous AI diagnostics). OSF Ventures brings more than just capital to portfolio companies. Its status as an active operating health system means founders gain access to clinical validation environments, practitioner networks, and patient populations that can meaningfully accelerate regulatory and commercial timelines, making the fund a strategic partner in addition to a financial backer.

OSK Ventures International Berhad (OSKVI) is a publicly listed venture capital and private equity firm established in 2000 and headquartered in Kuala Lumpur, Malaysia, trading on Bursa Malaysia under ticker 0053.KL. As the VC and PE affiliate of OSK Holdings Berhad, the platform provides patient growth capital to Malaysian and Southeast Asian technology companies across early-stage, late-stage, expansion, growth equity, and venture debt vehicles. A central pillar of the group is OSK-SBI Venture Partners, a 2018 joint venture with Tokyo-listed SBI Holdings, which invests out of successive Malaysia-domiciled funds and has managed multiple vehicles totaling $220 million since 2011. OSK Ventures has made approximately 55 investments across an active portfolio of 37 companies, spanning fintech, B2B SaaS, healthtech and telemedicine, e-commerce, ESG and carbon-emissions monitoring, compliance software, decentralized finance, digital asset exchange software, and enterprise technology. Portfolio companies include Endowus (Singapore digital wealth management, which participated in a $50 million-plus strategic round in January 2025), Doctor Anywhere, CompAsia, and AllRites. The fund's geographic focus spans Southeast Asia broadly, with Malaysia at the center. OSKVI's public listing on Bursa Malaysia, combined with its partnership with SBI Holdings, gives the firm a distinctive combination of local market credibility, institutional-grade governance, and access to Japanese corporate and financial networks. Founders backed by OSK Ventures gain a strategic investor with deep regional operating relationships and the institutional weight of a listed entity alongside the entrepreneurial connectivity of SBI's broader ecosystem.

OSS Capital, founded in 2018 by Joseph Jacks, Heather Meeker, and Nick White, is a San Francisco-based venture capital firm dedicated to the commercial open-source software (COSS) sector. OSS Capital has a strong focus on early-stage investments in enterprise applications, infrastructure, and innovative technology companies. Notable investments include companies like Plane, AppFlowy, and W4 Games. Their recent investments reflect their commitment to supporting transformative technologies in project management, software development, and media entertainment. OSS Capital's strategy emphasizes backing companies with robust open-source communities and leveraging their extensive network of co-investors, which includes notable figures like Naval Ravikant and funds like Sequoia Capital. OSS Capital's geographic focus spans the United States, India, and other international markets. The team, led by General Partner Joseph Jacks and supported by partners Heather Meeker and Bruce Perens, brings significant expertise in both the open-source and commercial software landscapes. They prioritize investments in companies that can benefit from deep technical insights and strategic support, ensuring these startups can scale effectively and sustainably​.

OTB Ventures is a European venture capital firm based in Amsterdam, focused on deep tech startups across Central and Eastern Europe. They specialize in sectors like space tech, artificial intelligence, automation, fintech, and cybersecurity. Founded by Adam Niewinski and Marcin Hejka, OTB Ventures aims to support founders with unique IP and global ambitions by providing early growth funding. Their portfolio includes notable companies like ICEYE, which specializes in radar satellite imagery; Silent Eight, an AI platform for financial crime detection; and Fractory, an automated on-demand metal manufacturing platform. Other significant investments include Turnkey Lender, an embedded lending platform, and Hydrosat, which provides thermal infrared imagery for analytics. OTB Ventures supports their portfolio companies with business and partner introductions, expertise in sales channels, and strategic guidance for international expansion. They are also involved in syndicating additional financing and preparing companies for successful exits.

OTV (formerly Olive Tree Ventures) is a global specialist venture capital firm exclusively dedicated to digital health, founded in 2015 and headquartered in Tel Aviv, Israel with additional offices in New York, Montreal, and Shanghai. Co-founded by General Partners Mayer Gniwisch, Amir Lahat, and Alejandro Weinstein, who together bring backgrounds spanning healthcare, technology, private equity, and financial services, the firm is widely recognized as Israel's only major VC whose primary investment focus is digital health. Partner Manor Zemer complements the founding team. OTV closed a dedicated $170 million digital-health growth fund in December 2020, anchoring its international expansion including the opening of its Asia office in Shanghai. The firm leads rounds across 45 investments and covers the full arc of digital health: telemedicine and virtual care, genomics, AI-powered clinical decision and diagnostics platforms, digital biomarkers, precision medicine, and next-generation medical-device software. Notable portfolio companies include TytoCare (remote examination kit, whose $50 million round OTV led alongside Insight Partners and Qualcomm Ventures) and Scopio Labs ($16 million Series B that OTV led in December 2023, advancing digital microscopy and AI pathology). Realized exits include Lemonaid Health (acquired by 23andMe) and Emedgene (acquired by Illumina). OTV focuses particularly on companies reaching commercial maturity, partnering with founders to navigate regulatory, reimbursement, and enterprise sales challenges across five continents. Its combination of Israeli innovation sourcing, US capital-market relationships, and Asian commercial networks makes it a genuinely global platform for digital health at growth stage.

OurCrowd, founded in 2013 and headquartered in Jerusalem, is a leading global venture capital platform. It offers accredited investors access to pre-vetted startups, exclusive venture funds, and alternative investments. The firm’s portfolio covers sectors such as healthcare, AI, robotics, energy, and fintech, with notable investments in Beyond Meat, JumpCloud, and Lemonade. Beyond Meat, a leader in plant-based foods, and Lemonade, an AI-driven insurance company, both had successful IPOs and continue to thrive. OurCrowd’s investment strategy involves thorough due diligence and active support for portfolio companies, ranging from seed to growth stages. They typically invest between $1 million and $5 million, offering strategic guidance and access to a global network of co-investors and operational support​. The firm operates globally, with a strong presence in Israel and the U.S., and investments in Europe, Asia, and Latin America. This global reach allows them to tap into diverse markets and innovative ecosystems. Led by CEO Jon Medved, OurCrowd’s team includes investment professionals across multiple offices worldwide, ensuring a comprehensive approach to emerging technologies and market opportunities. Startups seeking investment should highlight their innovation, scalability, and market potential, approaching OurCrowd through their network or platform to increase funding chances

Outbound Ventures, founded in 2015 and based in New York, focuses on early-stage investments in tech-enabled consumer-facing companies. They have made 54 investments and have had 16 successful exits, including companies like Mented Cosmetics, Hydra Studios, and Fleur Marché. The firm is led by co-founders Jimmy Thermiotis, Luis Gonzalez, and Nael Rasamny. Outbound Ventures prioritizes companies with self-aware and adaptable founding teams and leverages their extensive network across Latin America, the U.S., and the U.K. to support the growth of their portfolio companies. Notable investments include Treinta, a fintech company in Colombia; Nabis, a logistics software for the cannabis industry; and Moonshot Brands, a company focused on e-commerce and consumer goods. Their investment strategy typically involves rounds ranging from seed to Series A, with an average round size of $8 million.

Outset Capital is a specialized early-stage venture capital firm based in San Francisco, driven by a team of AI practitioners and serial entrepreneurs. Their investment focus is on AI, dev tools, robotics, and the future of work, making them a go-to partner for cutting-edge tech startups. They are particularly known for backing companies at the earliest stages, often before anyone else, with small but strategic investments that do not lead rounds. Instead, Outset prefers to add significant value through their hands-on approach, leveraging their deep operational experience to help founders scale from 0 to 1. Notable portfolio companies include Datology AI, Reflex, and SimpleHash, showcasing their focus on AI and software innovation. Outset Capital typically co-invests with leading firms like Andreessen Horowitz, Sequoia, and Lux Capital, reflecting their strong network and collaborative approach. Led by Ali Rohde, Josh Albrecht, and Kanjun Qiu, all of whom are based in San Francisco, the team’s unique blend of technical expertise and entrepreneurial success offers startups robust support beyond just capital. They maintain an active presence in the Bay Area’s startup community, organizing events and fostering a strong network of founders, engineers, and researchers. For startups looking to partner with Outset, the team values integrity, founder alignment, and a shared vision for long-term impact, making them more than just investors—they’re builders backing builders.

Outsiders Fund, founded in 2020 and based in New York, focuses on early-stage investments in disruptive technologies. The fund backs founders challenging traditional industries with innovative solutions. Outsiders Fund has a diverse portfolio across various sectors, including enterprise software, healthcare, cybersecurity, and aerospace. Notable investments include RaySecur, which provides mail and package security solutions using mmWave imaging technology; Casana, which offers remote patient monitoring via a smart toilet seat; and Dyania Health, which matches patients for clinical trials. Another significant investment is in Apex, a company focused on spacecraft manufacturing​. The fund typically invests in seed and early-stage rounds, with an average round size of $11M. Recent investments include Gradial, a generative AI content creation platform, and PaintJet, a robotics company specializing in painting commercial spaces. Led by Managing Partner Theodore Seem and supported by a team of experienced professionals, Outsiders Fund aims to partner with founders to drive growth and innovation in their respective fields. Their approach involves close collaboration with portfolio companies, providing strategic guidance and facilitating key industry connections.

Outsized Ventures is a venture capital fund based in London, specializing in deep tech and frontier technology startups that aim to tackle the world's most pressing challenges. The fund takes a unique approach by prioritizing people over technology, focusing on bold innovators who are not afraid to push boundaries. Notable investments include companies like Emitwise (carbon accounting software), Hoxton Farms (cultivated fat for meat alternatives), and Kernal Biologics (mRNA therapeutics), reflecting their commitment to groundbreaking science and technology. Outsized Ventures primarily invests in Europe, with a clear focus on early-stage ventures. Their strategy is founder-friendly, offering quick, transparent investment processes, sometimes closing deals within 48 hours. They often invest between fundraising rounds, helping founders maintain momentum without the distraction of constant fundraising. The team is led by experienced investors like Max, a former corporate lawyer and venture capitalist with extensive experience across Europe, Africa, and Asia, and Rod, a seasoned investor with a strong background in bioengineering startups. Outsized Ventures typically leads funding rounds and is known for offering "clean and unfussy" terms, making them an attractive partner for ambitious entrepreneurs aiming to make a significant impact. If you’re a visionary founder with a big dream, they’re the kind of investor who will back you all the way.

Outward VC is a London-based early-stage venture capital firm founded in 2017 by Co-Founders and General Partners Kevin Chong and Devin Kohli. Originally launched as the Outward Venture Capital Fund of Investec Bank, the firm has since grown into an independent platform dedicated to fintech and adjacent sectors, including healthcare, education, property, legal services, AI, and insurance. Outward's thesis holds that fintech extends well beyond traditional financial services and that the future of finance is more open, embedded, and intertwined with society-shifting challenges. The firm typically leads rounds up to GBP 5 million, investing at least 50 percent of the round, and reserves significant follow-on capital for portfolio companies. Outward leads rounds at pre-Series A stage and has backed approximately 100 founders to date. Portfolio highlights include Bud ($80 million Series B), Curve (GBP 133 million Series C), Peppy Health ($45 million Series B), Vauban (acquired by Carta), Clearglass, Exate, Orbital Witness, and Supercede. In September 2024 the firm announced the GBP 51 million first close of Fund II, anchored by a GBP 30 million cornerstone from the British Business Bank's Enterprise Capital Funds programme, with a target of GBP 100 million at second close. Recent Fund II investments include a GBP 2.5 million Seed round into Lombard-lending fintech Firenze in March 2025 and Steward AI in March 2026. Outward VC combines high conviction with meaningful ownership, taking a concentrated approach that allows it to dedicate real time and resource to each portfolio company. The firm's roots in the Investec network and its close relationship with the British Business Bank give founders access to institutional financial relationships alongside hands-on operating support.

Overkill Ventures, founded in 2017 and based in Riga, Latvia, is an angel fund that focuses on pre-seed investments in B2B technology startups across the Baltics, Nordics, Central Eastern Europe (CEE), and Commonwealth of Independent States (CIS). The firm emphasizes helping startups achieve product-market fit and scale their operations. Overkill Ventures has made 38 investments, with notable investments in companies like Paul-Tech, WeedBot, and MediNav. The firm is led by General Partners David Ventzel, Peter Marculans, and Dmitry Saikovsky, who bring extensive experience from startup accelerators and M&A activities. While Overkill Ventures is currently not making new investments directly, they continue to support early-stage startups through their sister funds, Accelerace and New Nordic Ventures.

AngelList, a prominent platform for startup investments, has facilitated investments in over 2,698 startups through its innovative syndicate and fund structures. Some of its notable investments include companies like Brex, Postmates, Cruise, and PillPack, which have grown significantly in their respective industries. AngelList offers various investment opportunities, including traditional funds, syndicates, and rolling funds, allowing investors to back startups on a deal-by-deal basis. The platform has democratized early-stage investing by providing individual accredited investors access to high-quality investment opportunities, often in collaboration with top-tier venture capital firms. For instance, AngelList has supported the growth of companies like Notion, Iterable, and MoonPay, providing them with the necessary capital to scale. Their full-service fund management capabilities streamline the investment process, from fund formation to managing cap tables and tax preparation, making it easier for new and experienced investors alike to participate in venture capital.

Overwater Ventures is an early-stage venture capital firm based in San Francisco, founded and led by Kristina Simmons, a former partner at Andreessen Horowitz and Chief of Staff at Khosla Ventures. The firm focuses on investing in breakthrough technologies that positively impact human health and the planet. Overwater Ventures closed its $20 million debut fund in April 2023, with backing from institutional family offices, experienced founders, and prominent investors like Vinod Khosla. The fund primarily targets sectors such as digital health, biotech, AI, robotics, climate tech, and future food. Notable portfolio companies include Overstory, which reduces power outages and wildfires, and Conceive, a fertility technology firm. Overwater Ventures is committed to providing holistic support to its founders, addressing not just business needs like marketing and fundraising but also personal well-being, including mental health and stress management.

OVO Fund, established in 2013 and headquartered in Palo Alto, California, specializes in early-stage venture capital investments, particularly in the pre-seed and seed stages. The firm focuses on backing "scary early-stage startups" with innovative ideas across various capital-efficient sectors. Their typical check size ranges from $250,000 to $500,000, with significant reserves for follow-on investments before the Series A stage. OVO Fund has a diverse portfolio of over 90 technology startups, including notable companies like Palantir, Wish, RelateIQ, Signifyd, Piazza, Addepar, and Juniper Square. Recent investments include companies such as Suma Wealth, a fintech company, and Clayful, an e-learning and wellness platform for children. The firm is led by experienced investors such as Eric Chen and Ilse Calderon, who provide strategic support to help their portfolio companies grow and succeed. OVO Fund is currently investing out of its second fund, which is valued at $35 million.

OVP Venture Partners (originally Olympic Venture Partners) was one of the Pacific Northwest's pioneer early-stage venture capital firms, founded in 1983 and headquartered in Kirkland, Washington, with an additional office in Portland, Oregon. Across nearly three decades of operation, OVP raised seven funds and managed more than $750 million in aggregate capital, led by Managing Directors Gerry Langeler, Chad Waite, and Bill Funcannon. The firm focused on information technology, software, digital media, communications, security, semiconductors, clean tech, and digital biology, with an emphasis on capital-efficient technology businesses in the western United States. OVP invested in approximately 102 companies across its history, generating 6 IPOs and 51 acquisitions. Early stakes in Qualcomm and Lam Research established the firm's track record. Later notable exits include NanoString Technologies (acquired by Bruker for $393 million in April 2024, OVP's most recent portfolio liquidity event), Cradlepoint, Fate Therapeutics, Aggregate Knowledge, Complete Genomics, Integrated Diagnostics, and RedSeal. The firm's seventh and final fund, OVP VII, was a $250 million 2006-vintage vehicle. In November 2012 OVP announced it would wind down and not raise an eighth fund, citing challenging fundraising conditions. OVP VII has since been liquidated. OVP Venture Partners is permanently closed to new investments. Its legacy portfolio has been fully managed to conclusion by the remaining partners, and the firm's track record stands as one of the most extensive in Pacific Northwest venture history, spanning four decades of technology investing and more than 50 successful exits across software, biotech, hardware, and communications.

Owl Ventures, founded in 2014 and based in Silicon Valley, is the largest venture capital firm dedicated to the education technology market, managing over $2 billion in assets. They specialize in investing across all stages from seed to late growth, focusing on transformative education companies. Notable investments include industry leaders like BYJU’s, MasterClass, Quizlet, and Newsela, which showcase their strategic emphasis on PreK-12, higher education, professional learning, and the intersection of EdTech with other sectors like FinTech and healthcare. Their investment strategy is hands-on, leveraging a global network of Limited Partners, distribution channels, and strategic partners to help portfolio companies scale effectively. Owl Ventures' approach includes support in talent acquisition, building syndicates, and navigating the education market's complexities. The firm is known for leading funding rounds and providing substantial check sizes, reflecting their active involvement in driving company growth and outcomes measurement. The team comprises experienced professionals like Managing Directors Ian Chiu, Tom Costin, Amit Patel, and Partner Malvika Bhagwat, each bringing deep domain expertise and a strong focus on education outcomes. Owl Ventures operates globally, with a strong presence in markets across North America, Europe, Asia, and Latin America, aiming to support innovative solutions that address the global skills gap and enhance educational accessibility and quality. Entrepreneurs seeking investment should note Owl Ventures’ preference for visionary leaders in EdTech, with an emphasis on scalable, impactful solutions. Approaching them with a clear demonstration of educational impact and market potential can significantly enhance partnership prospects.

Oxford Capital Partners, founded in 1999 and based in Oxford, UK, is a venture capital firm that focuses on investing in early-stage technology companies. The firm has invested approximately £500 million in over 100 businesses, emphasizing sectors such as fintech, digital health, artificial intelligence, and the future of retail. Their investment strategy leverages the UK's Enterprise Investment Scheme (EIS), providing tax advantages to investors and fostering innovation across the tech landscape. Oxford Capital seeks to back high-potential, disruptive technology with strong intellectual property or early signs of product-market fit. They typically aim to be the first institutional investor in these early-stage ventures, ranging from seed to Series A rounds. Their portfolio includes notable companies like Moneybox, Red Sift, and Attest. The firm prides itself on a hands-on approach, supporting founders with not only capital but also strategic guidance to help them achieve significant growth and scalability. The team, led by founder David Mott and including key members like Stephen Hampson and Chris Payne, brings a wealth of experience in venture capital and strategic investments. Oxford Capital's location in one of the world's leading knowledge clusters, Oxford, positions them advantageously to tap into cutting-edge innovations and support high-growth companies aiming to expand internationally.

Oxford Science Enterprises (OSE) is a venture capital firm deeply integrated with the University of Oxford, focusing on commercializing breakthrough scientific innovations. With a portfolio valued at over £2 billion, OSE invests in three core sectors: Life Sciences, Deep Tech, and Health Tech. It has partnered with over 200 leading academics from the university to build and support more than 80 high-impact companies. OSE’s strategy is to support early-stage ventures with long-term capital and hands-on expertise. Their investments span from biotechnology to quantum computing, with notable companies like Oxford Quantum Circuits, Ultromics, and Evox Therapeutics in the portfolio. OSE’s commitment to groundbreaking technologies is further emphasized by their mission to address global challenges such as health, food security, and sustainability. The firm is led by a distinguished team with deep ties to Oxford’s innovation ecosystem, including Jack Edmondson, the Chief Investment Officer, who has extensive experience managing large-scale investments at Oxford University Endowment Management. This alignment with Oxford enables OSE to identify and scale cutting-edge research into successful businesses. OSE’s model is designed to bridge the gap between academic discovery and market application, creating transformative companies that aim to improve human lives and drive future technological advancements.

Oxford Technology is a venture capital firm that specializes in investing in early-stage technology-based businesses. They manage both SEIS (Seed Enterprise Investment Scheme) and EIS (Enterprise Investment Scheme) funds, providing up to £150k in seed funding for SEIS companies and up to £300k in follow-on funding for EIS companies. Their focus is on science, technology, and engineering startups, primarily within a 60-mile radius of Oxford to facilitate active involvement with the companies. Notable investments by Oxford Technology include OxWash, which is developing sustainable laundry solutions; Refeyn, pioneering mass photometry for single molecules; and HydRegen, creating bio-based manufacturing technologies. They have also invested in innovative companies like Neuroute, which aggregates data for clinical trial recruitment, and Covatic, enabling personalized content creation without the need for tracking IDs. Oxford Technology aims to maximize shareholder value by working closely with their portfolio companies to achieve successful exits and providing ongoing support. Their investment strategy not only leverages tax reliefs but also focuses on creating successful companies with significant long-term growth potential.

Oxx VC is a venture capital firm specializing in B2B SaaS investments, focusing on scale-up stage companies in Europe and Israel. Founded in 2017, Oxx operates from London and Stockholm, providing essential growth capital and strategic resources to help companies achieve explosive growth. Notable investments by Oxx include Peak, a SaaS company leveraging AI for decision intelligence; Funnel, which offers marketing data hub solutions; and Codility, a platform for technical hiring. These investments highlight Oxx's commitment to supporting innovative software companies that have achieved product-market fit and are ready to scale. Oxx recently closed its second fund at €172 million, backed by institutional investors such as British Patient Capital, Saminvest, KfW Capital, and Argentum. This fund will continue to support SaaS companies through growth stages, particularly those focusing on AI-driven innovations. The firm, led by co-founders Richard Anton and Mikael Johnsson, prides itself on a selective, evidence-based investment approach, providing tailored support to each portfolio company. Oxx's mission is to help build global category leaders in the SaaS sector by combining deep industry knowledge, a strong network, and hands-on partnership.

Oyster Ventures, founded in 2016 and headquartered in San Francisco, is a venture capital firm that targets early-stage investments in frontier technology companies. The firm aims to drive innovation by investing in startups that bring liquidity and efficiency to traditional industries, support globalization, and have significant scaling potential. Notable companies in their portfolio include Ridepanda, Rithmm, and Advance, reflecting their diverse investment interests in specialty retail, business productivity software, and financial software. Key exits like Postmates and Clearbit highlight their success. Led by Sophie Liao and Ran Wang, Oyster Ventures is known for its hands-on approach and strategic support, helping portfolio companies navigate the complexities of growth and scale. The firm is particularly interested in technologies that can disrupt and modernize outdated systems, making industries more efficient and globally accessible. Their investment strategy focuses on identifying and nurturing startups with the potential to become market leaders through innovative solutions and robust business models. This approach has positioned Oyster Ventures as a significant player in the venture capital landscape, dedicated to fostering technological advancements and supporting visionary entrepreneurs.

Ozmen Ventures is a Reno, Nevada-based early-stage venture capital fund founded in 2016 by Eren and Fatih Ozmen, the owners of Sierra Nevada Corporation (SNC), a global national-security contractor specializing in aircraft modification, space components and systems, cybersecurity, and eHealth with 5,000 employees across 40 offices. Kerem Ozmen serves as Principal and Managing Director, also a co-founder of 8090 Industries. Operating from the Innevation Center in downtown Reno, the fund was established to back innovative solutions to traditional problems in northern Nevada and beyond, with a deliberate goal of seeding a venture ecosystem in a state historically underserved by coastal capital. Sector focus spans aerospace, artificial intelligence, fintech, healthcare, advanced computing, and consumer internet, reflecting deep-tech adjacencies that align with the Ozmen family's SNC expertise. The firm has made approximately eight investments across seven portfolio companies. Notable portfolio names include FiscalNote, which listed on NASDAQ in December 2020 at a $219 million market cap and stands as Ozmen Ventures' only IPO exit to date, alongside Bloq, Luminous Computing, Self Lender, Covered, and ClickBio (laboratory consumables). Check sizes have ranged from seed through early Series A. Ozmen Ventures operates as a family-office vehicle with a concentrated, long-duration portfolio strategy. Its investment cadence is deliberately measured rather than high-frequency, reflecting a philosophy of making fewer, more deeply supported bets rather than diversifying broadly. The fund's strongest comparative advantage is its connection to SNC's national-security and space-technology customer base, which can provide portfolio companies with non-dilutive contracts and enterprise validation.

P1 Ventures is a pan-African venture capital firm focused on supporting early-stage tech startups across the continent. Founded in 2020 by Mikael Hajjar and Hisham Halbouny, P1 Ventures aims to bridge the capital gap for African entrepreneurs by providing crucial early-stage funding. The firm has successfully raised $35 million in its second fund, with a target to reach $50 million. This fund supports sectors such as AI-powered SaaS, fintech, e-commerce, health tech, and more​. P1 Ventures distinguishes itself by leveraging AI in its investment processes, making it one of the first African VC firms to do so. This innovative approach helps identify promising startups and talent across Africa more efficiently. The firm is particularly interested in backing repeat founders and experienced operators with validated products and proven business models. Their portfolio includes companies like Yassir, an Algerian mobility platform, Money Fellows, an Egyptian savings app, Reliance Health, a Nigerian employee healthcare platform, and Chari, a Francophone-focused e-commerce and fintech app. P1 Ventures is committed to fostering innovation and supporting high-growth sectors that can make a significant impact across Africa​.

P101 Ventures, founded in 2013 and based in Milan, Italy, is a venture capital firm focusing on early-stage investments in the digital and technology sectors. With over 100 million euros under management, P101 is known for its commitment to nurturing innovative startups through capital, extensive networks, and strategic advisory. P101’s portfolio includes a variety of successful companies such as Tannico, an e-commerce platform for wine; BorsadelCredito.it, a peer-to-peer lending platform; and Cortilia, an online marketplace for fresh, local food products. The firm typically invests between 1 to 5 million euros per company and reserves additional capital for follow-on investments to support the continued growth of its portfolio companies. The firm's investment strategy involves active collaboration with founders, helping them design effective growth strategies and improve their ESG performance. P101 also leverages a strong network of strategic consultants, CEOs, and industry experts to provide deep operational and business development support​.

Pacific Health Ventures (PAC.VC) is a Silicon Valley-based healthcare venture capital firm founded in 2019 and headquartered in Menlo Park, California. The firm is an early-stage investor focused exclusively on B2B health technology, backing software-as-a-service platforms that improve clinical outcomes, streamline clinical and administrative workflows, and unlock new revenue for healthcare providers, payers, pharma companies, and employer customers. Pacific Health Ventures operates with a lean two-person investment team and runs a strategy of matching early-stage startups with strategic industry partners that have relevant gaps in their technology and service offerings, coupling seed and Series A capital with distribution and validation from large health-system and enterprise partners. The firm has built a concentrated portfolio of five active companies. Notable investments include SafelyYou (AI-powered fall prevention for senior living), Limbix (adolescent mental-health digital therapeutics), and Sika Health (HSA and FSA payments infrastructure). Pacific Health Ventures has made four Series A investments with an average round size of $12.7 million. The firm's most recent activity includes the Feeling Great $12 million Series A and the Relief Cardiovascular Series A, both announced in January 2025. Pacific Health Ventures distinguishes itself through its partner-matching model, which creates a pathway for portfolio companies to land and expand within large health enterprise customers before scaling broadly. This approach reduces the cold-start problem endemic to health technology sales cycles and gives founders both the capital and the institutional relationships needed to cross the proof-of-concept threshold into recurring enterprise revenue.

Page One Ventures is an early-stage Silicon Valley venture capital firm founded in 2020 by General Partner Mo El-Bibany and headquartered in San Francisco. The firm invests in software transforming existing markets and in deep technology creating entirely new ones, with stated focus areas in life sciences, deep tech, and B2B SaaS, with particular emphasis on data infrastructure and AI. Its thesis, captured in the firm's own phrasing, is that the future will be 'written in code and in codons,' reflecting a deliberate barbell between software and biology or hardware frontiers. The team of seven spans the United States and United Kingdom, with Venture Partners Ameena El-Bibany and Marc-Alexandre Saba complementing the founding GP. Through prior funds, the partners have backed more than 50 companies that have gone on to raise more than $1.5 billion in follow-on financing at an aggregate enterprise value exceeding $20 billion. As of October 2025, the Page One portfolio numbered approximately 68 companies across seed and Series A, including five unicorns and five acquired companies. Headline names include Dapper Labs, DataRobot, Ayar Labs (which reached unicorn status in 2024), and Portal Biotechnologies. The most recent reported new investment is GRO Biosciences in July 2024, and the most recent exit was Teampay, acquired by PayStand in April 2024. Page One takes a conviction-driven, founder-centric approach, deploying across both pre-seed and seed stages. The firm's interdisciplinary perspective across software and life sciences allows it to evaluate companies at the intersection of biology and computation that generalist funds may be poorly positioned to underwrite.

Paladin Capital Group is a global venture capital firm based in Washington, D.C., with additional offices in New York, Silicon Valley, London, and Luxembourg. Since its inception in 2001, Paladin has managed over $1 billion in committed capital, investing in more than 65 companies across North America, Europe, Australia, and South America. The firm focuses on innovative technology, particularly in cybersecurity, which has become a primary area of expertise. Notable investments include Corellium, which specializes in mobile and IoT virtualization; Digital Shadows, a provider of cyber situational awareness; and Expel, a company offering transparent managed security. Other significant portfolio companies include RangeForce, which offers a cyber simulation and skills analytics platform, and Hack The Box, an online cybersecurity training platform. Paladin Capital Group employs a dual-use investment approach, leveraging its knowledge of both commercial and government markets to provide unique insights and opportunities for its portfolio companies. This strategy helps startups develop strategic partnerships, access new markets, and navigate financing options. The firm is committed to adding value beyond capital by supporting portfolio companies with strategic guidance and leveraging its extensive network to maximize returns. Paladin has been actively involved in numerous successful exits, including the sale of Hubble Technologies to KKR-backed NetSPI.

Pale Blue Dot is a venture capital firm based in Malmö, Sweden, focused on early-stage investments in climate tech startups. Founded in 2020 by Joel Larsson, Heidi Lindvall, and Hampus Jakobsson, the firm aims to back founders addressing one of the most pressing global challenges: climate change. Pale Blue Dot invests in seed and pre-seed stage companies, typically with ticket sizes ranging from €500,000 to €2 million. They target businesses that offer scalable, innovative solutions to mitigate or reverse the effects of climate change. The firm’s portfolio spans diverse sectors, including foodtech, agtech, energy, logistics, and biotech, with notable investments in companies such as Monta, Hived, and Overstory. Their strategy involves leading or co-leading rounds, with a focus on companies based in Europe and the US. Pale Blue Dot has two funds: Fund I (€87 million) and Fund II (€93 million), demonstrating their commitment to investing in businesses that not only turn a profit but also have a significant, positive environmental impact. The fund places a strong emphasis on diversity and inclusion, aiming to back visionary leaders building sustainable and equitable companies. Their mission is to invest in technologies that will shape a future where every business operates as a net positive for the planet, aligning profit with impact. Pale Blue Dot views the climate crisis not just as a challenge, but as an opportunity to build the next generation of billion-dollar companies driving real-world change.